ADMA Biologics, Inc. (ADMA)
13.67
+0.43
(+3.25%)
USD |
NASDAQ |
Nov 13, 16:00
13.67
0.00 (0.00%)
After-Hours: 19:59
ADMA Biologics Total Assets (Quarterly) : 732.48M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 732.48M |
| June 30, 2026 | 684.21M |
| March 31, 2026 | 665.18M |
| December 31, 2025 | 633.35M |
| September 30, 2025 | 568.69M |
| June 30, 2025 | 558.38M |
| March 31, 2025 | 510.57M |
| December 31, 2024 | 498.38M |
| September 30, 2024 | 390.62M |
| June 30, 2024 | 376.40M |
| March 31, 2024 | 350.88M |
| December 31, 2023 | 329.18M |
| September 30, 2023 | 349.00M |
| June 30, 2023 | 343.03M |
| March 31, 2023 | 340.79M |
| December 31, 2022 | 348.46M |
| September 30, 2022 | 300.56M |
| June 30, 2022 | 296.93M |
| March 31, 2022 | 308.03M |
| December 31, 2021 | 276.25M |
| September 30, 2021 | 238.64M |
| June 30, 2021 | 232.81M |
| March 31, 2021 | 235.67M |
| December 31, 2020 | 207.67M |
| September 30, 2020 | 189.98M |
| Date | Value |
|---|---|
| June 30, 2020 | 191.54M |
| March 31, 2020 | 210.52M |
| December 31, 2019 | 127.09M |
| September 30, 2019 | 137.78M |
| June 30, 2019 | 143.27M |
| March 31, 2019 | 78.12M |
| December 31, 2018 | 88.88M |
| September 30, 2018 | 106.35M |
| June 30, 2018 | 117.75M |
| March 31, 2018 | 91.14M |
| December 31, 2017 | 108.02M |
| September 30, 2017 | 72.81M |
| June 30, 2017 | 84.64M |
| March 31, 2017 | 17.59M |
| December 31, 2016 | 23.69M |
| September 30, 2016 | 27.50M |
| June 30, 2016 | 31.74M |
| March 31, 2016 | 19.68M |
| December 31, 2015 | 23.71M |
| September 30, 2015 | 27.82M |
| June 30, 2015 | 29.80M |
| March 31, 2015 | 33.93M |
| December 31, 2014 | 27.23M |
| September 30, 2014 | 25.29M |
| June 30, 2014 | 27.88M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| BioMarin Pharmaceutical, Inc. | 11.57B |
| Nektar Therapeutics | 1.095B |
| Rhythm Pharmaceuticals, Inc. | 443.13M |
| Arcutis Biotherapeutics, Inc. | 524.43M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 293.98M |
| Shareholders Equity (Quarterly) | 438.51M |
| Debt to Equity Ratio | 0.4625 |
| Current Ratio | 6.044 |
| Net Debt Paydown Yield | -1.06% |